Smith & Nephew has a solid, growing business which will grow with market growth as well as by acquisition. It has a decent dividend payment history. Don't expect amazing performance, but on a mid- to ...

The CORI Digital Tensioner produces a surgeon-defined, quantifiable force to distract the knee joint, apply consistent tension to the ligaments, and provide objective gap data for procedure planning ...

In what has become an alarming trend in drug and medical device manufacturing, Smith and Nephew felt compelled to copycat other hip implant manufacturers and market a pair of dual modular hip stems.

Smith+Nephew SNN recently introduced the FAST-FLIX FLEX Meniscal Repair System, which is the only device to provide a surgeon-guided, bendable needle and shaft allowing access to all zones of the ...

Smith+Nephew expects full-year reported growth of around 5.7%, reaffirming its prior guidance. It anticipates an expansion of ...

Business: Smith & Nephew is a British portfolio medical technology company that operates worldwide. The company develops, manufactures, markets and sells medical devices and services. Its segments ...

In 2023, ambulatory surgery centers, especially physician-owned ones, surged in arthroscopic procedures, pushing suppliers for competitive pricing, curbing inflation, and limiting market growth.” — Dr ...

An announcement from Smith & Nephew Snats ( ($SNN) ) is now available. Smith & Nephew plc announced on November 19, 2025, that key executives ...

Smith & Nephew Snats ( ($SNN) ) has issued an announcement. On November 6, 2025, Smith & Nephew plc announced a significant transaction involving ...

LONDON, April 24, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORI™ Digital Tensioner - a purpose built device that lets ...